These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9523840)

  • 1. Abnormal cholesterol biosynthesis produced by AY 9944 in the rat leads to skeletal deformities similar to the Smith-Lemli-Opitz syndrome.
    Batta AK; Salen G
    J Lab Clin Med; 1998 Mar; 131(3):192-3. PubMed ID: 9523840
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal cholesterol biosynthesis as in Smith-Lemli-Opitz syndrome disrupts normal skeletal development in the rat.
    Kolf-Clauw M; Chevy F; Ponsart C
    J Lab Clin Med; 1998 Mar; 131(3):222-7. PubMed ID: 9523845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of ventral cell populations in the developing brain in a rat model of the Smith-Lemli-Opitz syndrome.
    Gofflot F; Kolf-Clauw M; Clotman F; Roux C; Picard JJ
    Am J Med Genet; 1999 Nov; 87(3):207-16. PubMed ID: 10564872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smith-Lemli-Opitz syndrome produced in rats with AY 9944 treated by intravenous injection of lipoprotein cholesterol.
    Chambers CM; McLean MP; Ness GC
    Am J Med Genet; 1997 Jan; 68(3):322-7. PubMed ID: 9024567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome.
    Salen G; Tint GS; Xu G; Batta AK; Irons M; Elias ER
    Ital J Gastroenterol; 1995 Dec; 27(9):506-8. PubMed ID: 8919321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in serum sterols of rats treated with 7-dehydrocholesterol-delta 7-reductase inhibitors: comparison to levels in humans with Smith-Lemli-Opitz syndrome.
    Wolf C; Chevy F; Pham J; Kolf-Clauw M; Citadelle D; Mulliez N; Roux C
    J Lipid Res; 1996 Jun; 37(6):1325-33. PubMed ID: 8808767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol biosynthesis inhibited by BM15.766 induces holoprosencephaly in the rat.
    Kolf-Clauw M; Chevy F; Siliart B; Wolf C; Mulliez N; Roux C
    Teratology; 1997 Sep; 56(3):188-200. PubMed ID: 9358606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cholesterol in embryonic development.
    Roux C; Wolf C; Mulliez N; Gaoua W; Cormier V; Chevy F; Citadelle D
    Am J Clin Nutr; 2000 May; 71(5 Suppl):1270S-9S. PubMed ID: 10799401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol deficit but not accumulation of aberrant sterols is the major cause of the teratogenic activity in the Smith-Lemli-Opitz syndrome animal model.
    Gaoua W; Wolf C; Chevy F; Ilien F; Roux C
    J Lipid Res; 2000 Apr; 41(4):637-46. PubMed ID: 10744785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 7-dehydrocholesterol reductase by the teratogen AY9944: a rat model for Smith-Lemli-Opitz syndrome.
    Kolf-Clauw M; Chevy F; Wolf C; Siliart B; Citadelle D; Roux C
    Teratology; 1996 Sep; 54(3):115-25. PubMed ID: 8987154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal and inhibited cholesterol synthesis in the cultured rat embryo.
    Llirbat B; Wolf C; Chevy F; Citadelle D; Bereziat G; Roux C
    J Lipid Res; 1997 Jan; 38(1):22-34. PubMed ID: 9034197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Smith-Lemli-Opitz syndrome: a potentially fatal birth defect caused by a block in the last enzymatic step in cholesterol biosynthesis.
    Tint GS; Batta AK; Xu G; Shefer S; Honda A; Irons M; Elias ER; Salen G
    Subcell Biochem; 1997; 28():117-44. PubMed ID: 9090293
    [No Abstract]   [Full Text] [Related]  

  • 13. Disorders of cholesterol biosynthesis.
    Clayton PT
    Arch Dis Child; 1998 Feb; 78(2):185-9. PubMed ID: 9579167
    [No Abstract]   [Full Text] [Related]  

  • 14. Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features.
    Fliesler SJ; Peachey NS; Richards MJ; Nagel BA; Vaughan DK
    Arch Ophthalmol; 2004 Aug; 122(8):1190-200. PubMed ID: 15302661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal cholesterol biosynthesis in sitosterolaemia and the Smith-Lemli-Opitz syndrome.
    Salen G; Shefer S; Batta AK; Tint GS; Xu G; Honda A
    J Inherit Metab Dis; 1996; 19(4):391-400. PubMed ID: 8884563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic isoprenoid metabolism in a rat model of Smith-Lemli-Opitz Syndrome.
    Keller RK; Mitchell DA; Goulah CC; Fliesler SJ
    Lipids; 2013 Mar; 48(3):219-29. PubMed ID: 23361583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized derivatives of 7-dehydrocholesterol induce growth retardation in cultured rat embryos: a model for antenatal growth retardation in the Smith-Lemli-Opitz syndrome.
    Gaoua W; Chevy F; Roux C; Wolf C
    J Lipid Res; 1999 Mar; 40(3):456-63. PubMed ID: 10064734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant pathways in the late stages of cholesterol biosynthesis in the rat. Origin and metabolic fate of unsaturated sterols relevant to the Smith-Lemli-Opitz syndrome.
    Ruan B; Tsai J; Wilson WK; Schroepfer GJ
    J Lipid Res; 2000 Nov; 41(11):1772-82. PubMed ID: 11060346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling by the human serotonin(1A) receptor is impaired in cellular model of Smith-Lemli-Opitz Syndrome.
    Paila YD; Murty MR; Vairamani M; Chattopadhyay A
    Biochim Biophys Acta; 2008 Jun; 1778(6):1508-16. PubMed ID: 18381059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the biochemical abnormality in the Smith-Lemli-Opitz syndrome.
    Batta AK; Salen G
    Indian J Pediatr; 1996; 63(2):143-7. PubMed ID: 10829981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.